Erratum: Risk factors for prognosis in patients with severely decreased GFR (Kidney International Reports (2018) 3 (625-637) DOI: 10.1016/j.ekir.2018.01.002 PII: S246802491830007X)

Maccabi Health System, Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid of a Nurse Practitioner (MASTERPLAN), Modification of Diet in Renal Disease Study (MDRD), Nanjing CKD Network Cohort Study (Nanjing CKD), NephroTest Study, National RenalHealthcareProgram-Uruguay (NRHP-URU), New Zealand Diabetes Cohort Study (NZDCS), Parcours de Soins des Personnes Agées (PSPA), Primary-Secondary Care Partnership to Prevent Adverse Outcomes in Chronic Kidney Disease (PSP CKD), Racial and Cardiovascular Risk Anomalies in CKD Cohort (RCAV), Reduction of Endpoints in Non-insulin Dependent Diabetes Mellitus with the Angiotensin II Antagonist Losartan (RENAAL), Stockholm CREAtinine Measurements Cohort (SCREAM), Second Manifestations of ARTerial Disease Study (SMART), Swedish Renal Registry CKD Cohort (SRR CKD), Sunnybrook Cohort, West of Scotl and CKD Study, CKD Prognosis Consortium Steering Committee, CKD Prognosis Consortium Data Coordinating Center, Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference on Prognosis and Optimal Management of Patients with Advanced CKD, Chronic Kidney Disease (CKD) Prognosis ConsortiumCKD Prognosis Consortium investigators/collaborators, African American Study of Kidney Disease and Hypertension (AASK), British Columbia CKD Study (BC CKD), Canadian Study of Prediction of Death, Dialysis and Interim Cardiovascular Events (CanPREDDICT), Cleveland Clinic CKD Registry Study (CCF), Chronic Renal Impairment in Birmingham (CRIB), Chronic Renal Insufficiency Cohort Study (CRIC), Chronic Renal Insufficiency Standards Implementation Study (CRISIS), German Chronic Kidney Disease Study (GCKD), Geisinger Health System, Grampian Laboratory Outcomes, Morbidity and Mortality Studies - 2 (GLOMMS2), Gonryo Study, Hong Kong CKD Studies

Research output: Contribution to journalComment/debate

Abstract

The Chronic Kidney Disease (CKD) Prognosis Consortium is a collaborative author of the above-mentioned article. The CKD Prognosis Consortium investigators/collaborators are as follows: • African American Study of Kidney Disease and Hypertension (AASK): Brad Astor, Lawrence J. Appel; British Columbia CKD Study (BC CKD): Adeera Levin, Ognjenka Djurdjev; Canadian Study of Prediction of Death, Dialysis and Interim Cardiovascular Events (CanPREDDICT): Adeera Levin, Mila Tang, Ognjenka Djurdjev; Cleveland Clinic CKD Registry Study (CCF): Sankar D. Navaneethan, Stacey E. Jolly, Jesse D. Schold, Joseph V. Nally Jr; Chronic Renal Impairment in Birmingham (CRIB): David C. Wheeler, Jonathan Emberson, John Townend, Martin Landray; Chronic Renal Insufficiency Cohort Study (CRIC): Harold I. Feldman, Chi-yuan Hsu, James P. Lash, Lawrence J. Appel; Chronic Renal Insufficiency Standards Implementation Study (CRISIS): Philip A. Kalra, James P. Ritchie, Raman Maharajan, Helen Alderson, Beverly Lane; German Chronic Kidney Disease Study (GCKD): Kai-Uwe Eckardt, Markus P. Schneider, Anna Köttgen, Florian Kronenberg, Barbara Bärthlein; Geisinger Health System: Alex R. Chang, Jamie A. Green, H. Lester Kirchner, Kevin Ho; Grampian Laboratory Outcomes, Morbidity and Mortality Studies – 2 (GLOMMS2): Angharad Marks, Corri Black, Gordon J. Prescott, Nick Fluck; Gonryo Study: Masaaki Nakayama, Mariko Miyazaki, Tae Yamamoto, Gen Yamada; Hong Kong CKD Studies: Angela Yee-Moon Wang, Sharon Cheung, Sharon Wong, Jessie Chu, Henry Wu; Maccabi Health System: Varda Shalev, Gabriel Chodick; Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid of a Nurse Practitioner (MASTERPLAN): Peter J. Blankestijn, Jack F.M. Wetzels, Arjan D. van Zuilen, Jan A. van den Brand; Modification of Diet in Renal Disease Study (MDRD): Andrew S. Levey, Lesley A. Inker, Mark J. Sarnak, Hocine Tighiouart; Nanjing CKD Network Cohort Study (Nanjing CKD): Haitao Zhang; NephroTest Study: Benedicte Stengel; National Renal Healthcare Program – Uruguay (NRHP-URU): Pablo G. Rios, Nelson Mazzuchi, Liliana Gadola, Verónica Lamadrid, Laura Sola; New Zealand Diabetes Cohort Study (NZDCS): John F. Collins, C. Raina Elley, Timothy Kenealy; Parcours de Soins des Personnes Agées (PSPA): Olivier Moranne, Cecile Couchoud, Cecile Vigneau; Primary-Secondary Care Partnership to Prevent Adverse Outcomes in Chronic Kidney Disease (PSP CKD): Nigel J. Brunskill, Rupert W. Major, David Shepherd, James F. Medcalf; Racial and Cardiovascular Risk Anomalies in CKD Cohort (RCAV): Csaba P. Kovesdy, Kamyar Kalantar-Zadeh, Miklos Z. Molnar, Keiichi Sumida, Praveen K. Potukuchi; Reduction of Endpoints in Non-insulin Dependent Diabetes Mellitus with the Angiotensin II Antagonist Losartan (RENAAL): Hiddo J.L. Heerspink, Dick de Zeeuw, Barry Brenner; Stockholm CREAtinine Measurements Cohort (SCREAM): Juan Jesus Carrero, Peter Barany, Abdul Rashid Qureshi, Carl-Gustaf Elinder; Second Manifestations of ARTerial Disease Study (SMART): Frank L.J. Visseren, Yolanda van der Graaf; Swedish Renal Registry CKD Cohort (SRR CKD): Marie Evans, Maria Stendahl, Staffan Schön, Mårten Segelmark, Karl-Göran Prütz; Sunnybrook Cohort: David M. Naimark, Navdeep Tangri; West of Scotland CKD Study: Patrick B. Mark, Jamie P. Traynor, Colin C. Geddes, Peter C. Thomson.• CKD Prognosis Consortium Steering Committee: Alex R. Chang, Josef Coresh (Chair), Ron T. Gansevoort, Morgan E. Grams, Anna Köttgen, Andrew S. Levey, Kunihiro Matsushita, Mark Woodward, Luxia Zhang.• CKD Prognosis Consortium Data Coordinating Center: Shoshana H. Ballew (Assistant Project Director), Jingsha Chen (Programmer), Josef Coresh (Principal Investigator), Morgan E. Grams (Director of Nephrology Initiatives), Lucia Kwak (Programmer), Kunihiro Matsushita (Director), Yingying Sang (Lead Programmer), Aditya Surapaneni (Programmer), Mark Woodward (Senior Statistician).• Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference on Prognosis and Optimal Management of Patients with Advanced CKD: Kai-Uwe Eckardt (Conference Co-Chair), Brenda R. Hemmelgarn (Conference Co-Chair), David C. Wheeler (KDIGO Co-Chair), Wolfgang C. Winkelmayer (KDIGO Co-Chair), John Davis (CEO), Danielle Green (Managing Director), Michael Cheung (Chief Scientific Officer), Tanya Green (Communications Director), Melissa McMahan (Programs Director).

Original languageEnglish (US)
Number of pages1
JournalKidney International Reports
Volume3
Issue number6
DOIs
StatePublished - Nov 1 2018

ASJC Scopus subject areas

  • Ophthalmology
  • Nephrology

Fingerprint Dive into the research topics of 'Erratum: Risk factors for prognosis in patients with severely decreased GFR (Kidney International Reports (2018) 3 (625-637) DOI: 10.1016/j.ekir.2018.01.002 PII: S246802491830007X)'. Together they form a unique fingerprint.

  • Cite this

    Maccabi Health System, Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid of a Nurse Practitioner (MASTERPLAN), Modification of Diet in Renal Disease Study (MDRD), Nanjing CKD Network Cohort Study (Nanjing CKD), NephroTest Study, National RenalHealthcareProgram-Uruguay (NRHP-URU), New Zealand Diabetes Cohort Study (NZDCS), Parcours de Soins des Personnes Agées (PSPA), Primary-Secondary Care Partnership to Prevent Adverse Outcomes in Chronic Kidney Disease (PSP CKD), Racial and Cardiovascular Risk Anomalies in CKD Cohort (RCAV), Reduction of Endpoints in Non-insulin Dependent Diabetes Mellitus with the Angiotensin II Antagonist Losartan (RENAAL), Stockholm CREAtinine Measurements Cohort (SCREAM), Second Manifestations of ARTerial Disease Study (SMART), Swedish Renal Registry CKD Cohort (SRR CKD), Sunnybrook Cohort, West of Scotl and CKD Study, CKD Prognosis Consortium Steering Committee, CKD Prognosis Consortium Data Coordinating Center, Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference on Prognosis and Optimal Management of Patients with Advanced CKD, ... Hong Kong CKD Studies (2018). Erratum: Risk factors for prognosis in patients with severely decreased GFR (Kidney International Reports (2018) 3 (625-637) DOI: 10.1016/j.ekir.2018.01.002 PII: S246802491830007X). Kidney International Reports, 3(6). https://doi.org/10.1016/j.ekir.2018.08.009